Roles of Mas-related G protein–coupled receptor X2 on mast cell–mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases
Mast cells (MCs), which are granulated tissue-resident cells of hematopoietic lineage, contribute
to vascular homeostasis, innate/adaptive immunity, and wound healing. However, MCs …
to vascular homeostasis, innate/adaptive immunity, and wound healing. However, MCs …
[HTML][HTML] Merkel cell carcinoma: epidemiology, prognosis, therapy and unmet medical needs
…, C Lebbé, A Zur Hausen, MF Avril, S Hariharan… - European journal of …, 2017 - Elsevier
Merkel cell carcinoma (MCC) is a rare skin cancer that is associated with Merkel cell polyomavirus
infection in most cases. Incidence rates of MCC have increased in past decades. Risk …
infection in most cases. Incidence rates of MCC have increased in past decades. Risk …
[HTML][HTML] Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinoma
…, A Chudnovsky, C Fowst, S Hariharan… - … England Journal of …, 2019 - Mass Medical Soc
Background In a single-group, phase 1b trial, avelumab plus axitinib resulted in objective
responses in patients with advanced renal-cell carcinoma. This phase 3 trial involving …
responses in patients with advanced renal-cell carcinoma. This phase 3 trial involving …
Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial
…, S Oudard, ME Gore, J Tarazi, S Hariharan… - The Lancet …, 2013 - thelancet.com
Background In a phase 3 trial comparing the efficacy and safety of axitinib versus sorafenib
as second-line treatment for metastatic renal cell carcinoma, patients given axitinib had a …
as second-line treatment for metastatic renal cell carcinoma, patients given axitinib had a …
Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer
…, P Ellis, M Byrne, M Morrison, S Hariharan… - Journal of clinical …, 2006 - ascopubs.org
Purpose Etoposide and cisplatin (EP) has been a standard treatment for extensive-disease
small-cell lung cancer (SCLC). An earlier phase III trial reported improved survival for …
small-cell lung cancer (SCLC). An earlier phase III trial reported improved survival for …
[HTML][HTML] Non-muscle-invasive bladder cancer: An overview of potential new treatment options
Aim This review article summarizes the current clinical practice guidelines around disease
definitions and risk stratifications, and the treatment of non-muscle-invasive bladder cancer (…
definitions and risk stratifications, and the treatment of non-muscle-invasive bladder cancer (…
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial
…, GA Bjarnason, S Oudard, S Hariharan… - The lancet …, 2009 - thelancet.com
Background Results from clinical trials have established sunitinib as a standard of care for
first-line treatment of advanced or metastatic renal-cell carcinoma (RCC); however, many …
first-line treatment of advanced or metastatic renal-cell carcinoma (RCC); however, many …
Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib
…, DP Cohen, DR Lu, I Chen, S Hariharan… - Journal of the …, 2011 - academic.oup.com
Background Hypertension (HTN) is an on-target effect of the vascular endothelial growth
factor pathway inhibitor, sunitinib. We evaluated the association of sunitinib-induced HTN with …
factor pathway inhibitor, sunitinib. We evaluated the association of sunitinib-induced HTN with …
Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial
…, MT Campbell, K Penkov, JL Lee, S Hariharan… - Nature medicine, 2020 - nature.com
We report on molecular analyses of baseline tumor samples from the phase 3 JAVELIN
Renal 101 trial (n = 886; NCT02684006 ), which demonstrated significantly prolonged …
Renal 101 trial (n = 886; NCT02684006 ), which demonstrated significantly prolonged …
Optical methodology for detecting histologically unapparent nanoscale consequences of genetic alterations in biological cells
Recently, there has been a major thrust to understand biological processes at the nanoscale.
Optical microscopy has been exceedingly useful in imaging cell microarchitecture. …
Optical microscopy has been exceedingly useful in imaging cell microarchitecture. …
